OQROGet OQRO Pro
Insider trade

Mirum Pharmaceuticals (MIRM)Director sold ~$112K

Laura Brege, Director at Mirum Pharmaceuticals, sold ~$112K of Mirum Pharmaceuticals shares.

~$112K
Approx. value · 1,491 sh @ $75.07
16K
Holds after · shares reported
Traded
Sep 11, 2025
Filed
Sep 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 7, 2025Insider · 2 peopleInsiders: 2 sales (~$2.8M)
  2. Aug 11, 2025InsiderCEO sold ~$2.48M of MIRM shares in the open market
  3. Sep 11, 2025 · this disclosureInsiderDirector sold ~$112K of MIRM shares in the open market

What came next

  1. Sep 11, 2025InsiderDirector sold ~$1.15M of MIRM shares in the open market
  2. Sep 12, 2025InsiderCFO sold ~$728K of MIRM shares in the open market
  3. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
  4. Dec 6, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 2 more items)
  5. Dec 18, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Mirum Pharmaceuticals

For Mirum Pharmaceuticals, OQRO holds 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MIRM page.

Other recent filings by Laura Brege, Director

The full history of Laura Brege, Director is on the profile page.

How this filing works

Other disclosures at Mirum Pharmaceuticals

Everything OQRO holds on this company is on its MIRM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data